指南与共识慢性肾脏病急性肾损伤水电解质与酸碱

糖尿病、肾脏病或心血管疾病患者生病日用药指导的共识建议:一项改良德尔菲法

Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process.
指南 / 共识 · Am J Kidney Dis · 2022-12-05

通过改良德尔菲法,来自4个国家10个临床学科的26名临床专家就生病日用药指导(SDMG)达成共识,形成42条具体建议,涵盖触发SDMG的容量不足症状、需紧急联系医护的体征、患者自我管理策略及药物停用与恢复原则。

要点

  • 容量不足症状应触发SDMG;意识下降、严重呕吐、低血压、酮体阳性、心动过速和发热应紧急联系医护。
  • 共识认为肾素-血管紧张素系统抑制剂、利尿剂、非甾体抗炎药、钠-葡萄糖共转运蛋白2抑制剂和二甲双胍应暂时停用。
  • 胰岛素、磺脲类和格列奈类仅在血糖低时停用;血糖高时基础与餐时胰岛素增加10%-20%。

核心结论

  • 多学科临床专家组就容量不足症状和体征情况下的SDMG建议、自我管理策略及用药指导达成共识。
  • 这些建议可能为未来SDMG策略试验的设计提供参考。

研究设计与样本

  • 改良德尔菲法,遵循德尔菲研究执行与报告指南。
  • 通过目的性和滚雪球抽样招募与SDMG相关的国际临床专家。
  • 先进行文献范围综述,随后进行3轮连续的建议制定、完善和投票。
  • 会议以虚拟方式举行,结构化安排以便参与者提供意见并快速优先排序和提炼想法。
  • 最终专家组包括来自4个国家和10个临床学科的26名临床参与者。

主要发现

  • 参与者就42条具体建议达成共识:5条关于应触发SDMG的容量不足伴随症状和体征。
  • 6条关于应促使紧急联系医护人员的体征,包括意识水平下降、严重呕吐、低血压、酮体存在、心动过速和发热。
  • 14条关于患者自我管理的场景和策略,包括频繁监测血糖、检查酮体、液体摄入和进食以预防低血糖。
  • 共识认为肾素-血管紧张素系统抑制剂、利尿剂、非甾体抗炎药、钠-葡萄糖共转运蛋白2抑制剂和二甲双胍应暂时停用。
  • 参与者建议胰岛素、磺脲类和格列奈类仅在血糖低时停用,血糖高时基础与餐时胰岛素增加10%-20%。

关键数值与推荐

  • 共识定义为>75%同意。
  • 42条具体建议达成共识:5条关于容量不足症状和体征,6条关于紧急联系医护的体征,14条关于患者自我管理,6条关于恢复用药。
  • 共识认为肾素-血管紧张素系统抑制剂、利尿剂、非甾体抗炎药、钠-葡萄糖共转运蛋白2抑制剂和二甲双胍应暂时停用。
  • 参与者建议胰岛素、磺脲类和格列奈类仅在血糖低时停用,血糖高时基础与餐时胰岛素增加10%-20%。
  • 就症状缓解后24-48小时内及正常饮食模式恢复时恢复用药的6条建议达成共识。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 参与者来自高收入国家,以加拿大为主。
  • 研究结果可能无法推广到其他环境实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Sick day medication guidance (SDMG) involves withholding or adjusting specific medications in the setting of acute illnesses that could contribute to complications such as hypotension, acute kidney injury (AKI), or hypoglycemia. We sought to achieve consensus among clinical experts on recommendations for SDMG that could be studied in future intervention studies. STUDY DESIGN: A modified Delphi process following guidelines for conducting and reporting Delphi studies. SETTING & PARTICIPANTS: An international group of clinicians with expertise relevant to SDMG was recruited through purposive and snowball sampling. A scoping review of the literature was presented, followed by 3 sequential rounds of development, refinement, and voting on recommendations. Meetings were held virtually and structured to allow the participants to provide their input and rapidly prioritize and refine ideas. OUTCOME: Opinions of participants were measured as the percentage who agreed with each recommendation, whereas consensus was defined as >75% agreement. ANALYTICAL APPROACH: Quantitative data were summarized using counts and percentages. A qualitative content analysis was performed to capture the context of the discussion around recommendations and any additional considerations brought forward by participants. RESULTS: The final panel included 26 clinician participants from 4 countries and 10 clinical disciplines. Participants reached a consensus on 42 specific recommendations: 5 regarding the signs and symptoms accompanying volume depletion that should trigger SDMG; 6 regarding signs that should prompt urgent contact with a health care provider (including a reduced level of consciousness, severe vomiting, low blood pressure, presence of ketones, tachycardia, and fever); and 14 related to scenarios and strategies for patient self-management (including frequent glucose monitoring, checking ketones, fluid intake, and consumption of food to prevent hypoglycemia). There was consensus that renin-angiotensin system inhibitors, diuretics, nonsteroidal anti-inflammatory drugs, sodium/glucose cotransporter 2 inhibitors, and metformin should be temporarily stopped. Participants recommended that insulin, sulfonylureas, and meglitinides be held only if blood glucose was low and that basal and bolus insulin be increased by 10%-20% if blood glucose was elevated. There was consensus on 6 recommendations related to the resumption of medications within 24-48 hours of the resolution of symptoms and the presence of normal patterns of eating and drinking. LIMITATIONS: Participants were from high-income countries, predominantly Canada. Findings may not be generalizable to implementation in other settings. CONCLUSIONS: A multidisciplinary panel of clinicians reached a consensus on recommendations for SDMG in the presence of signs and symptoms of volume depletion, as well as self-management strategies and medication instructions in this setting. These recommendations may inform the design of future trials of SDMG strategies.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Watson KE, Dhaliwal K, Robertshaw S, et al. Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process. Am J Kidney Dis. 2022. PMID: 36470530. doi:10.1053/j.ajkd.2022.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。